IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 45 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $8 | -99.9% | 22,052 | +44.0% | 0.00% | – |
Q3 2022 | $6,000 | -53.8% | 15,316 | -45.0% | 0.00% | – |
Q2 2022 | $13,000 | +550.0% | 27,825 | +813.8% | 0.00% | – |
Q1 2022 | $2,000 | -33.3% | 3,045 | -38.5% | 0.00% | – |
Q4 2021 | $3,000 | +200.0% | 4,948 | +494.7% | 0.00% | – |
Q3 2021 | $1,000 | -90.9% | 832 | -90.5% | 0.00% | – |
Q2 2021 | $11,000 | 0.0% | 8,733 | +8.2% | 0.00% | – |
Q1 2021 | $11,000 | -54.2% | 8,070 | +21.6% | 0.00% | -100.0% |
Q4 2020 | $24,000 | +700.0% | 6,634 | +388.9% | 0.00% | – |
Q3 2020 | $3,000 | +50.0% | 1,357 | +55.8% | 0.00% | – |
Q2 2020 | $2,000 | – | 871 | +254.1% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 246 | -98.6% | 0.00% | -100.0% |
Q4 2019 | $32,000 | -17.9% | 17,286 | +27.6% | 0.00% | 0.0% |
Q3 2019 | $39,000 | +105.3% | 13,544 | +83.9% | 0.00% | +200.0% |
Q2 2019 | $19,000 | +46.2% | 7,365 | +46.8% | 0.00% | 0.0% |
Q1 2019 | $13,000 | -48.0% | 5,016 | -44.0% | 0.00% | -50.0% |
Q4 2018 | $25,000 | +150.0% | 8,955 | +732.2% | 0.00% | +100.0% |
Q3 2018 | $10,000 | – | 1,076 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |